메뉴 건너뛰기
Journal of Clinical Psychiatry
Volumn 72, Issue 3, 2011, Pages 412-413
Number needed to treat: What it is and what it isn't, and why every clinician should know how to calculate it
Author keywords

[No Author keywords available]
Indexed keywords

AKATHISIA; EFFECT SIZE; MEDICAL DECISION MAKING; NUMBER NEEDED TO HARM; NUMBER NEEDED TO TREAT; PRIORITY JOURNAL; RELAPSE; REMISSION; SEDATION; SHORT SURVEY; STATISTICAL PARAMETERS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN;
EID: 79953038244     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11ac06874     Document Type: Short Survey
Times cited : (32)
References (7)
  • 1
    • 43549112900 scopus 로고    scopus 로고
    • Compelling or irrelevant? Using number needed to treat can help decide
    • DOI 10.1111/j.1600-0447.2008.01194.x
    • Citrome L. Compelling or irrelevant? using number needed to treat can help decide. Acta Psychiatr Scand. 2008;117(6):412-419. (Pubitemid 351678479)
    • (2008) Acta Psychiatrica Scandinavica , vol.117 , Issue.6 , pp. 412-419
    • Citrome, L.1
  • 2
    • 67749114366 scopus 로고    scopus 로고
    • Quantifying risk: The role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications
    • Citrome L. Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications. Curr Drug Saf. 2009;4(3):229-237.
    • (2009) Curr Drug Saf , vol.4 , Issue.3 , pp. 229-237
    • Citrome, L.1
  • 3
    • 77956626923 scopus 로고    scopus 로고
    • Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: An analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed
    • Citrome L. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed. Postgrad Med. 2010;122(4):39-48.
    • (2010) Postgrad Med , vol.122 , Issue.4 , pp. 39-48
    • Citrome, L.1
  • 4
    • 46949084286 scopus 로고    scopus 로고
    • Antipsychotics for the treatment of schizophrenia: Likelihood to be helped or harmed, understanding proximal and distal benefits and risks
    • DOI 10.1586/14737175.8.7.1079
    • Citrome L, Kantrowitz J. Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks. Expert Rev Neurother. 2008;8(7):1079-1091. (Pubitemid 351962075)
    • (2008) Expert Review of Neurotherapeutics , vol.8 , Issue.7 , pp. 1079-1091
    • Citrome, L.1    Kantrowitz, J.2
  • 5
    • 33746740474 scopus 로고    scopus 로고
    • Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat
    • DOI 10.1097/00004850-200609000-00004, PII 0000485020060900000004
    • Cookson J, Gilaberte I, Desaiah D, et al. Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat. Int Clin Psychopharmacol. 2006;21(5):267-273. (Pubitemid 44162478)
    • (2006) International Clinical Psychopharmacology , vol.21 , Issue.5 , pp. 267-273
    • Cookson, J.1    Gilaberte, I.2    Desaiah, D.3    Kajdasz, D.K.4
  • 6
    • 33744907008 scopus 로고    scopus 로고
    • Size of Treatment Effects and Their Importance to Clinical Research and Practice
    • DOI 10.1016/j.biopsych.2005.09.014, PII S0006322305012102
    • Kraemer HC, Kupfer DJ. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry. 2006;59(11):990-996. (Pubitemid 43849650)
    • (2006) Biological Psychiatry , vol.59 , Issue.11 , pp. 990-996
    • Kraemer, H.C.1    Kupfer, D.J.2
  • 7
    • 73549118356 scopus 로고    scopus 로고
    • Relative vs absolute measures of benefit and risk: What's the difference?
    • Citrome L. Relative vs absolute measures of benefit and risk: what's the difference? Acta Psychiatr Scand. 2010;121(2):94-102.
    • (2010) Acta Psychiatr Scand , vol.121 , Issue.2 , pp. 94-102
    • Citrome, L.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.